Eurobio Scientific (ALERS) | Stock Overview & Key Data
Eurobio Scientific S.A. | Mid-cap | Healthcare
Eurobio Scientific S.A. | Mid-cap | Healthcare
Eurobio Scientific Performance Comparison
Stock Range
Today's Range
Low: €25.35
High: €25.55
on August 22, 2025
52 Week Range
Low: €23.20
High: €26.50
on April 7, 2025
on January 31, 2025
All-Time High: €29.76 on December 27, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€251.9M
EPS
0.39
P/E Ratio (TTM)
64.36
Forward P/E
22.61
P/B Ratio
1.41
PEG Ratio
N/A
Div. Yield
N/A
ROE
2.26%
Beta
0.382
Debt to Equity
5.46
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
16.08%
Profit Margin
2.58%
Returns and Earnings
Return on Assets (TTM)
4.34%
Return on Equity (TTM)
2.26%
EBITDA
€28.8M
Net Income (TTM)
€4.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€15.43
Quarterly Revenue Growth (YoY)
14.30%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Eurobio Scientific ALERS | 251.86M Mid-cap | -0.39% | 1.00% | 0.00% | -0.39% | 0.00% | 2.43% | 32.11% | 120.00% |
| Guerbet S.A GBT | 293.77M Mid-cap | -1.34% | 2.80% | 9.70% | -18.03% | -17.72% | -34.38% | 12.16% | -25.38% |
| Median Technologies ALMDT | 91.70M Small-cap | -12.31% | 14.08% | 5.38% | -10.31% | -44.58% | -66.28% | -77.83% | -63.62% |
| Affluent Medical AFME | 60.00M Small-cap | 14.58% | 32.00% | 18.71% | 23.13% | 18.71% | -15.38% | -42.71% | -79.25% |
| Novacyt S.A ALNOV | 34.83M Small-cap | -2.04% | 2.13% | 2.13% | -18.64% | -21.31% | -58.97% | -57.14% | -85.88% |
| Theraclion S.A ALTHE | 31.40M Small-cap | 9.23% | 86.84% | 153.57% | 273.68% | 97.22% | 136.67% | -36.61% | -44.09% |
Ownership & Short Interest
Insider Ownership
0.09%
Institutional Ownership
92.86%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
417
Average 90-Day Volume
394
Eurobio Scientific Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Eurobio Scientific would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALERS's 52-week high and low?
- In the last 52 weeks, Eurobio Scientific reached a high of €26.50 (on January 31, 2025) and a low of €23.20 (on April 7, 2025).
- What is the market cap and P/E ratio for ALERS?
- Curious about Eurobio Scientific's size and valuation? Its market capitalization stands at 251.86M. When it comes to valuation, the P/E ratio (trailing twelve months) is 64.36, and the forward P/E (looking ahead) is 22.61.
- Does ALERS pay dividends? If so, what's the yield?
- As for dividends, Eurobio Scientific isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Eurobio Scientific's main competitors or similar companies to consider before investing?
When looking at Eurobio Scientific, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Guerbet S.A
GBT293.77M Healthcare Medical Devices -34.38% 12.16% Median Technologies
ALMDT91.70M Healthcare Medical Devices -66.28% -77.83% Affluent Medical
AFME60.00M Healthcare Medical Devices -15.38% -42.71% Novacyt S.A
ALNOV34.83M Healthcare Medical Devices -58.97% -57.14% Theraclion S.A
ALTHE31.40M Healthcare Medical Devices 136.67% -36.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Eurobio Scientific S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Eurobio Scientific's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.26%, the Debt to Equity ratio from the most recent quarter is 5.46, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALERS?
- Looking at Eurobio Scientific's growth, its revenue over the trailing twelve months (TTM) was €155M. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALERS stock is held by insiders and institutions?
- Wondering who owns Eurobio Scientific stock? Company insiders (like executives and directors) hold about 0.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 92.86%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.